Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma

NCT06292039 | Not Yet Recruiting

• 2 other identifiers: P05557882KL2TR001870
• Study Type: interventional
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is: • Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors? Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

Conditions

Injury Traumatic; Survivorship; Trauma Injury

Keywords

Social determinants of health; Community-engaged research; Unmet needs

Outcome Measures

Primary Outcomes (1)

• Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility

  Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting."

  8-12 weeks post-pathway enrollment

Secondary Outcomes (4)

• Participant pathway resource utilization - type

  8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year

• Participant pathway resource utilization - frequency

  8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year

• Participant pathway resource utilization - duration

  8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year

• Participant pathway resource utilization - % utilized

  8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year

Study Arms (1)

Injury Thrivorship Pathway

EXPERIMENTAL

Enrollment in the human-centered injury thrivorship pathway.

Other: Human-Centered Injury Thrivorship Pathway

Interventions

Human-Centered Injury Thrivorship Pathway OTHER

Enrollment in the human-centered injury thrivorship pathway.

Injury Thrivorship Pathway

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
• Admitted to the hospital ≥ 24 hours
• Discharged from the hospital alive
• San Francisco resident or unhoused in San Francisco
• Capacity for informed consent

You may not qualify if:

• Patient \< 18 years old
• Deceased during index hospitalization
• Unable to provide informed consent

Sponsors & Collaborators

• University of California, San Francisco: lead
• National Center for Advancing Translational Sciences (NCATS): collaborator

Study Sites (1)

Zuckerberg San Francisco General Hospital

San Francisco, California, 94110, United States

Location

Related Publications (1)

• Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7.

  PMID: 20957426 BACKGROUND

MeSH Terms

Conditions

Wounds and Injuries; Accidental Injuries

Study Officials

• Marissa A Boeck, MD, MPH

  University of California, San Francisco

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Marissa A Boeck, MD, MPH

CONTACT

415-502-4745; marissa.boeck@ucsf.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 14, 2024
• First Posted: March 4, 2024
• Study Start (Estimated): January 1, 2027
• Primary Completion (Estimated): June 1, 2027
• Study Completion (Estimated): June 1, 2027
• Last Updated: May 1, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)